在前列腺癌研究中使用ChatGPT-4进行简要总结,以推进以患者为中心的沟通:大规模的生成AI性能评估
Emily Rinderknecht1,2, Simon U Engelmann2, Veronika Saberi2
1Working Group on Artificial Intelligence and Digitalization of the German Society of Urology, Germany.
Journal of medical Internet research
|November 19, 2025
概括
聊天GPT-4显著提高了前列腺癌研究的简要总结质量,在可读性和准确性方面超过了人类编写的版本. 优化的提示提升了人工智能生成的摘要,以改善科学沟通.
科学领域:
- 生物医学文献分析
- 科学出版中的人工智能
- 卫生沟通健康沟通
背景情况:
- 生物医学文献的复杂性挑战了公众的理解.
- 简要概述旨在提高健康素养和公众信任.
- 目前的简要概述往往缺乏清晰度,因为在普通语言的培训有限.
研究的目的:
- 评估ChatGPT-4在产生前列腺癌方面的有效性.
- 评估快速设计如何影响人工智能生成摘要的质量.
- 为在科学出版中使用生成性AI提供指导.
主要方法:
- 从瘤学期刊中提取了204篇前列腺癌文章.
- 使用ChatGPT-4生成简单和扩展提示的简要概要.
- 对可读性 (FKRE),事实准确性 (专家评分) 和字数进行评估的摘要.
主要成果:
- 聊天GPT-4总结显示了比原始更好的可读性和事实准确性.
- 扩展提示比简单提示产生更高的可读性得分.
- 人工智能生成的摘要 (79.4%的扩展提示) 的高质量评分明显高于原件 (5.4%).
结论:
- 优化的提示使ChatGPT-4能够生成高质量的简要概要.
- 生成型人工智能集成可以增强非专家受众的科学交流.
- 进一步的研究应该包括非专业人士的评估和更广泛的临床领域.
关键词:
人工智能在出版业中的应用癌症信息的可访问性 癌症信息的可访问性数字健康沟通数字健康沟通提高健康识字能力人与人工智能的协作大型语言模型.自然语言的生成.患者参与度 患者参与度快速的工程提示提示工程可读性评估可读性评估更多相关视频
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
1.3K
08:05Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
1.1K
相关概念视频
Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
